Similar articles

• Chemotherapy for biliary tract cancer in Japan.

  Okusaka T. Okusaka T. Semin Oncol. 2002 Dec;29(6 Suppl 20):51-3. doi: 10.1053/sonc.2002.37377. Semin Oncol. 2002. PMID: 12577234 Review.
• A step forward in the treatment of advanced biliary tract cancer.

  Wolpin BM, Mayer RJ. Wolpin BM, et al. N Engl J Med. 2010 Apr 8;362(14):1335-7. doi: 10.1056/NEJMe1001183. N Engl J Med. 2010. PMID: 20375411 No abstract available.
• Gemcitabine doublets in advanced pancreatic cancer: should we move on?

  Rocha Lima CM, Flores AM. Rocha Lima CM, et al. J Clin Oncol. 2006 Jan 20;24(3):327-9. doi: 10.1200/JCO.2005.03.8315. Epub 2005 Dec 12. J Clin Oncol. 2006. PMID: 16344312 No abstract available.
• Chemotherapy in biliary tract carcinomas: results in India.

  Doval DC, Sekhon JS, Gupta SK, Gupta S, Awasthy BS. Doval DC, et al. Semin Oncol. 2002 Dec;29(6 Suppl 20):46-50. doi: 10.1053/sonc.2002.37375. Semin Oncol. 2002. PMID: 12577233 Review.
• Brief commentary: largest randomized trial of biliary tract cancer treatment with cisplatin plus gemcitabine versus gemcitabine alone: an excellent opportunity to evaluate the prognostic value of tumor marker CA 19-9.

  Copur MS, Obermiller A. Copur MS, et al. Clin Colorectal Cancer. 2011 Mar 1;10(1):70-1. doi: 10.3816/CCC.2011.n.012. Clin Colorectal Cancer. 2011. PMID: 21609939 Clinical Trial. No abstract available.